Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SANDEEP GUPTA

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1063500353
CMS profile
320961
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$18,003.69

107 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–107 of 107 matching records. This page contains 7 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SANDEEP GUPTA

NPI 1063500353 · CMS profile ID 320961

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–107 of 107 matching records. This page contains 7 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1063500353?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SANDEEP GUPTA, NPI 1063500353, CMS profile ID 320961. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–107 of 107 matching records. This page contains 7 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1063500353?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SANDEEP GUPTA, NPI 1063500353, CMS profile ID 320961. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–107 of 107 matching records. This page contains 7 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1063500353?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SANDEEP GUPTA, NPI 1063500353, CMS profile ID 320961, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–107 of 107 matching records. This page contains 7 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1063500353?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

107 matching records · $18,003.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 107 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–107 of 107.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ANI Pharmaceuticals, Inc. $25.8101/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034133237 CMS
GlaxoSmithKline, LLC. $15.0601/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002524729 CMS
Electromed, Inc. $17.2501/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 977387007 CMS
Grifols USA, LLC $26.9001/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011780407 CMS
AstraZeneca Pharmaceuticals LP $138.3101/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016066355 CMS
GlaxoSmithKline, LLC. $4.1901/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002522367 CMS
GlaxoSmithKline, LLC. $1.3401/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002524707 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $22,820.76 68
PY2020 $14,965.44 53
PY2021 $20,557.63 52
PY2022 $38,753.77 85
PY2023 $18,003.69 107
PY2024 $1,394.28 56
PY2025 $1,652.34 63

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $440,775.69 104
PY2024 Principal investigator $484,703.62 54
PY2023 Principal investigator $55,754.00 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

104 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $352.00 12/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LL
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211642764
Principal investigator 1 Verona Pharma, Inc. $1,053.00 12/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891579
Principal investigator 1 Verona Pharma, Inc. $1,170.00 12/12/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891575
Principal investigator 1 GlaxoSmithKline, LLC. $8,625.00 12/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTIC No dispute reported 06/30/2026 1192177804
Principal investigator 1 GlaxoSmithKline, LLC. $12,000.00 12/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTIC No dispute reported 06/30/2026 1192177808
Principal investigator 1 Genentech, Inc. $3,000.00 11/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643116
Principal investigator 1 Verona Pharma, Inc. $600.75 11/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891577
Principal investigator 1 Verona Pharma, Inc. $39,546.24 11/03/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891533
Principal investigator 1 Verona Pharma, Inc. $351.00 11/03/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891571
Principal investigator 1 Verona Pharma, Inc. $700.00 10/10/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891569
Principal investigator 1 Verona Pharma, Inc. $351.00 10/10/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891573
Principal investigator 1 Genentech, Inc. $70.00 09/24/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643042
Principal investigator 1 Genentech, Inc. $3,336.00 09/24/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643056
Principal investigator 1 Genentech, Inc. $2,500.00 09/24/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643076
Principal investigator 1 Genentech, Inc. $400.00 09/24/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643108
Principal investigator 1 Verona Pharma, Inc. $351.00 09/24/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891449
Principal investigator 1 Genentech, Inc. $2,000.00 09/17/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643194
Principal investigator 1 Genentech, Inc. $1,500.00 09/17/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643197
Principal investigator 1 Genentech, Inc. $2,000.00 09/17/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643203
Principal investigator 1 Verona Pharma, Inc. $1,053.00 09/17/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891447
Principal investigator 1 Verona Pharma, Inc. $702.00 09/02/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891445
Principal investigator 1 Verona Pharma, Inc. $2,450.00 09/02/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891519
Principal investigator 1 Verona Pharma, Inc. $702.00 08/27/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891433
Principal investigator 1 Verona Pharma, Inc. $351.00 08/27/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891435
Principal investigator 1 Genentech, Inc. $58,968.00 08/22/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643046
Principal investigator 1 Genentech, Inc. $2,198.00 08/20/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643215
Principal investigator 1 Verona Pharma, Inc. $12,000.00 08/15/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891469
Principal investigator 1 Verona Pharma, Inc. $1,800.00 08/15/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891471
Principal investigator 1 Verona Pharma, Inc. $5,000.00 08/15/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD No dispute reported 06/30/2026 1232891513
Principal investigator 1 Genentech, Inc. $1,000.00 08/13/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643080
Principal investigator 1 Genentech, Inc. $5,442.00 08/08/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643054
Principal investigator 1 Genentech, Inc. $8,000.00 08/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643187
Principal investigator 1 Genentech, Inc. $3,073.00 08/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643190
Principal investigator 1 Genentech, Inc. $6,941.00 07/18/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643183
Principal investigator 1 Genentech, Inc. $1,600.00 07/16/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643060
Principal investigator 1 Genentech, Inc. $1,200.00 07/11/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643209
Principal investigator 1 Genentech, Inc. $2,500.00 07/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643178
Principal investigator 1 Genentech, Inc. $14,000.00 07/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643219
Principal investigator 1 Genentech, Inc. $2,948.00 06/23/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643021
Principal investigator 1 Genentech, Inc. $1,400.00 06/18/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642939
Principal investigator 1 Genentech, Inc. $1,000.00 06/18/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642981
Principal investigator 1 Genentech, Inc. $3,073.00 06/18/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643171
Principal investigator 1 Genentech, Inc. $6,941.00 06/11/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643164
Principal investigator 1 Genentech, Inc. $1,674.00 06/06/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643035
Principal investigator 1 Genentech, Inc. $400.00 06/04/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642943
Principal investigator 1 Genentech, Inc. $400.00 05/30/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642962
Principal investigator 1 Genentech, Inc. $600.00 05/30/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643013
Principal investigator 1 Genentech, Inc. $400.00 05/28/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642967
Principal investigator 1 Genentech, Inc. $1,600.00 05/28/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642988
Principal investigator 1 Genentech, Inc. $800.00 05/28/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643002
Principal investigator 1 Genentech, Inc. $600.00 05/23/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642971
Principal investigator 1 Genentech, Inc. $1,400.00 05/23/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643011
Principal investigator 1 Genentech, Inc. $14,985.00 05/21/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642934
Principal investigator 1 Genentech, Inc. $800.00 05/21/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642975
Principal investigator 1 Genentech, Inc. $4,743.00 05/21/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643175
Principal investigator 1 Genentech, Inc. $400.00 05/16/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643024
Principal investigator 1 Genentech, Inc. $800.00 05/14/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211643038
Principal investigator 1 Genentech, Inc. $155.00 05/14/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643162
Principal investigator 1 Genentech, Inc. $837.00 05/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642978
Principal investigator 1 Genentech, Inc. $7,615.00 05/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643167
Principal investigator 1 Genentech, Inc. $1,200.00 04/30/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642919
Principal investigator 1 Genentech, Inc. $5,022.00 04/25/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642985
Principal investigator 1 Genentech, Inc. $5,543.00 04/16/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Ph III OLE of Astegolimab in COPD No dispute reported 06/30/2026 1211643157
Principal investigator 1 Genentech, Inc. $3,348.00 04/11/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642946
Principal investigator 1 Genentech, Inc. $1,674.00 04/04/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642958
Principal investigator 1 Genentech, Inc. $2,030.00 04/01/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643154
Principal investigator 1 Genentech, Inc. $6,696.00 03/28/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642880
Principal investigator 1 Genentech, Inc. $5,022.00 03/21/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642870
Principal investigator 1 Genentech, Inc. $5,075.00 03/05/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643139
Principal investigator 1 Genentech, Inc. $3,349.00 03/05/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643148
Principal investigator 1 Genentech, Inc. $28,566.00 02/28/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642806
Principal investigator 1 Genentech, Inc. $200.00 02/26/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642767
Principal investigator 1 Genentech, Inc. $1,000.00 02/26/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642783
Principal investigator 1 Genentech, Inc. $1,600.00 02/26/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642843
Principal investigator 1 Genentech, Inc. $2,030.00 02/26/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643151
Principal investigator 1 Genentech, Inc. $800.00 02/21/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642900
Principal investigator 1 Genentech, Inc. $1,600.00 02/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642826
Principal investigator 1 Genentech, Inc. $1,400.00 02/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642852
Principal investigator 1 Genentech, Inc. $1,200.00 02/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642877
Principal investigator 1 Genentech, Inc. $400.00 02/19/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642903
Principal investigator 1 Genentech, Inc. $400.00 02/14/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642770
Principal investigator 1 Genentech, Inc. $1,400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642776
Principal investigator 1 Genentech, Inc. $1,800.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642792
Principal investigator 1 Genentech, Inc. $800.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642796
Principal investigator 1 Genentech, Inc. $400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642799
Principal investigator 1 Genentech, Inc. $400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642803
Principal investigator 1 Genentech, Inc. $1,000.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642813
Principal investigator 1 Genentech, Inc. $400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642817
Principal investigator 1 Genentech, Inc. $400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642820
Principal investigator 1 Genentech, Inc. $400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642839
Principal investigator 1 Genentech, Inc. $1,000.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642859
Principal investigator 1 Genentech, Inc. $600.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642874
Principal investigator 1 Genentech, Inc. $600.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642888
Principal investigator 1 Genentech, Inc. $800.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642891
Principal investigator 1 Genentech, Inc. $400.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642895
Principal investigator 1 Genentech, Inc. $14,313.00 02/07/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643136
Principal investigator 1 Genentech, Inc. $800.00 01/31/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642788
Principal investigator 1 Genentech, Inc. $800.00 01/31/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642835
Principal investigator 1 Genentech, Inc. $9,504.00 01/29/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642823
Principal investigator 1 Genentech, Inc. $3,915.00 01/22/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642831
Principal investigator 1 Genentech, Inc. $12,879.00 01/14/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211642863
Principal investigator 1 AstraZeneca Pharmaceuticals LP $39,229.70 01/08/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK
A Randomized DoubleBlind Parallel Group Multi Center Phase III Study to Assess the Efficacy of Budesonide Glycopyrronium and Formoterol Fumarate MeterednDose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease THARROS No dispute reported 06/30/2026 1185546655
Principal investigator 1 Genentech, Inc. $3,073.00 01/08/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643144
Principal investigator 1 Genentech, Inc. $5,250.00 01/03/2025 Non-covered Recipient Entity
RESEARCH PHYSICIANS NETWORK LLC
PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD No dispute reported 06/30/2026 1211643133